Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Critical Investing Workshop -- Ignore unavailable to you. Want to Upgrade?

To: lindelgs who wrote (22960)	6/21/2000 12:25:00 PM
From: Ritch	Respond to of 35685

She handled the return flight just fine. The meds did their job. She enjoyed the shopping as well. Can't wait for the next get together. I don't remember the last time I enjoyed a weekend as much. Ritch

To: lindelgs who wrote (22960)	6/21/2000 12:52:00 PM
From: lindelgs	Respond to of 35685

Nice to see Agilent moving up...some news: Agilent Technologies Introduces the First Release of Rosetta Resolver Data Analysis System for Gene Expression Research PALO ALTO, Calif.--(BW HealthWire)--June 21, 2000--Agilent Technologies Inc. (NYSE: A) today announced the first release of the Rosetta Resolver(TM) Expression Data Analysis System for life science research, marking the beginning of a series of exclusive gene expression technologies resulting from the strategic alliance between Agilent and Rosetta Inpharmatics Inc. The alliance, announced last December, is expected to result in new tools that will greatly accelerate the work of researchers as they begin analyzing the vast quantities of data generated by the genomics revolution. The Rosetta Resolver is a turnkey, enterprise-wide, gene-expression, bioinformatics solution for the pharmaceutical, biotechnology, and agriculture industries that enables researchers to simultaneously monitor multiple pathways and targets within a cell -- a capability referred to as "comprehensive target profiling." When combined with Agilent's innovative DNA microarray technologies, Rosetta Resolver gives scientists a powerful tool to quickly identify new target genes of interest in the quest for new drugs and foods. The Rosetta Resolver system combines software, hardware and database architecture to enable storage, retrieval and high-level analysis of massive volumes of expression data. This solution is ideal for pharmaceutical, biotechnology and agricultural companies needing to assess compound specificity, identify new genes or targets, or compare compound profiles to gold standards for existing drugs or agrochemicals. This enterprise-wide system combines flexibility and ease of use with high-performance algorithms to produce rapid, accurate results from complex gene expression data. The system can accept and analyze data from most commonly used expression profiling technologies, and from single or multiple experiments. "We are pleased to offer the exclusive Rosetta Resolver bioinformatics system to our customers in Europe, Japan and the U.S. who are using gene expression analysis to identify new drug candidates. Agilent is committed to providing the highest caliber tools to enable drug discovery and the Rosetta Resolver system will strongly complement our current DNA microarray offering," said Richard D. (Rick) Kniss, senior vice president and general manager of Agilent's Chemical Analysis Group. "Our customers will now be able to glean a lot more information from their arrays through access to this software that offers powerful advanced visualization and analysis capabilities for mining gene expression array data in an enterprise-wide solution." U.S. Availability The Rosetta Resolver product line is available in several flexible packages designed to meet the needs of both large and small organizations. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a diversified technology company, resulting from Hewlett-Packard Company's realignment into two fully independent companies. With approximately 43,000 employees serving customers in more than 120 countries, Agilent Technologies is a global leader in designing and manufacturing test, measurement and monitoring instruments, systems and solutions, and semiconductor and optical components. The company serves markets that include communications, electronics, life sciences and healthcare. In fiscal year 1999, the businesses comprising Agilent, then a subsidiary of HP, had net revenue of more than $8.3 billion. Information about Agilent Technologies can be found on the Web at www.agilent.com. Note to Editors: Rosetta Resolver is a U.S. trademark of Rosetta Inpharmatics, Inc. -------------------------------------------------------------------------------- Contact: Agilent Technologies Bill Gette, 650/857-3708 bill_gette@agilent.com Doug Forsyth, 650/857-5603 doug_forsyth@agilent.com